Short-Term Creatine Supplementation May Alleviate the Malnutrition-Inflammation Score and Lean Body Mass Loss in Hemodialysis Patients: A Pilot Randomized Placebo-Controlled Trial
Marini ACB, Motobu RD, Freitas ATV, Mota JF, Wall BT, Pichard C, Laviano A, Pimentel GD
JPEN. Journal of parenteral and enteral nutrition · 14 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (clasificado por nuestro filtro de IA)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2019-09-18 · JPEN J Parenter Enteral Nutr · vol. 44 · número 5 · págs. 815–822
- Editorial
- Wiley
- Citado
- 74 citas · más que el 70% de estudios similares · 0.9× el promedio de su campo
- Referencias
- 28 trabajos
- Acceso
- Acceso abierto (copia en repositorio) · CC-BY
- Áreas de investigación
- Dialysis and Renal Disease Management · Nutrition and Health in Aging · Muscle metabolism and nutrition
- Palabras clave
- Creatine, Lean body mass, Medicine, Placebo, Randomized controlled trial, Internal medicine, Hemodialysis, Maltodextrin, Malnutrition, Creatine Monohydrate, Nutritional Supplementation, Gastroenterology, Endocrinology, Body weight, Chemistry
- MeSH
- muscle, skeletal, humans, malnutrition, inflammation, creatine, renal dialysis, pilot projects, double-blind method, body composition, quality of life, dietary supplements, adolescent, adult, middle aged, female, male, young adult
8 autores
- Ana Clara B. Marini🇧🇷Universidade Federal de Goiás
- Reika D. Motobu🇧🇷Universidade Federal de Goiás
- Ana Tereza Vaz de Souza Freitas🇧🇷Universidade Federal de Goiás
- João Felipe Mota🇧🇷Universidade Federal de Goiás
- Benjamin Toby Wall🇬🇧University of Exeter
- Claude Pichard🇨🇭University Hospital of Geneva
- Alessandro Laviano🇮🇹Sapienza University of Rome
- Gustavo D. Pimentel🇧🇷 · autor de correspondenciaUniversidade Federal de Goiás
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Creatine supplementation has been proposed to alleviate muscle loss in various populations, but has not been investigated in hemodialysis (HD) patients. Thus, our objective was to evaluate whether creatine supplementation could attenuate the loss of lean body mass (LBM) and malnutrition-inflammation score (MIS) in HD patients.
Methods
A randomized, placebo-controlled, double blind, parallel-design study included HD patients, of both sexes, aged 18-59 years. The patients were allocated to a Placebo Group (PG; n = 15; received maltodextrin, 1st week: 40 g/day and 2nd-4th weeks: 10 g/day) and a Creatine Group (CG; n = 15; received creatine plus maltodextrin, 1st week: 20 g/day of creatine plus 20 g/day of maltodextrin and 2nd-4th weeks: 5 g/day of creatine plus 5 g/day of maltodextrin). Pre and post the intervention, patients were evaluated for food intake, MIS, body composition and biochemical parameters.
Results
CG group attenuated the MIS (Pre: 5.57 ± 0.72 vs. Post: 3.85 ± 0.47 score, P = 0.003) compared with PG (Pre: 5.71 ± 0.97 vs. Post: 5.36 ± 0.95 score, P = 0.317) (supplement × time P = 0.017, effect size: 0.964). The change of LBM was greater in CG than in PG (CG: Δ0.95 vs PG: Δ0.13 kg). At post-intervention, 28.6% of PG patients presented LBM loss and 71.4% remain stable. In contrast, 14.4% of CG patients had LBM loss, 42.8% remain stable and 42.8% gained. Food intake and quality of life did not change. CG increased the BMI and gait speed in post-compared to pre-moment, but no difference among the groups.
Conclusion
In HD patients, four weeks of creatine supplementation may alleviate the MIS as well as attenuate the LBM loss compared to placebo.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.